A multicenter phase II trial of neoadjuvant letrozole plus low‐dose cyclophosphamide in postmenopausal patients with estrogen receptor‐positive breast cancer (JBCRG‐07): therapeutic efficacy and clinical implications of circulating endothelial cells

Neoadjuvant endocrine therapy has been reported to decrease tumor size, which leads to increased breast conservation rates. To improve the clinical response, metronomic chemotherapy with endocrine therapy is a promising strategy. A multicenter phase II single‐arm neoadjuvant trial with letrozole and...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Med
Main Authors: Ueno, Takayuki, Masuda, Norikazu, Kamigaki, Shunji, Morimoto, Takashi, Akiyama, Futoshi, Kurosumi, Masafumi, Tsuda, Hitoshi, Mikami, Yoshiki, Tanaka, Sunao, Morita, Satoshi, Toi, Masakazu
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2018
Teme:
Clinical Cancer Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6010720/
https://ncbi.nlm.nih.gov/pubmed/29733541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1516
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki